Skip to main content
KyungdongPharm logo

KyungdongPharm — Investor Relations & Filings

Ticker · 011040 ISIN · KR7011040003 KO Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2023-02-15 Notice of Dividend Amou…
Country KR South Korea
Listing KO 011040

About KyungdongPharm

https://kdpharma.co.kr

KyungdongPharm is a pharmaceutical company engaged in the development, manufacturing, and distribution of medicines. Since its establishment in 1975, the company has focused on producing a broad portfolio of specialized therapeutic drugs and general pharmaceuticals. Its product lines encompass prescription medicines, with a focus on areas such as liver therapy, and over-the-counter products, including its prominent painkiller brand, 'Geunal-N'. The company also manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates. Utilizing advanced production facilities and proprietary technology, KyungdongPharm is dedicated to developing high-quality medicines supported by clinical research to contribute to public health.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Kyungdong Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected payment date. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2023-02-15 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Kyungdong Pharmaceutical. It outlines the date, location, and agenda items (approval of financial statements, election of directors and auditors, and remuneration limits). This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and to request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2023-02-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report insider shareholdings and transactions by company directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions or ownership status by company directors and executives.
2023-01-06 Korean
[기재정정]유형자산취득결정(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean stock market (DART system) regarding a 'Correction Report' (정정신고) for a 'Decision to Acquire Tangible Assets' (유형자산취득결정). It details changes in acquisition price and payment dates for real estate. Since this is a specific regulatory disclosure regarding corporate asset acquisition that does not fit into the other specialized categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-12-29 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the upcoming meeting's administrative requirements. Given it is a regulatory announcement regarding meeting logistics, it fits best under the RNS category.
2022-12-15 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Kyung Dong Pharmaceutical Co., Ltd. (경동제약(주)) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial statements, business operations, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.